Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Zero Order, first Order and Second Order Derivative Spectrophotometric Methods for Determination of Buproprionhcl in Pharmaceutical formulation


Affiliations
1 Department of Pharmaceutical Quality Assurance, Vidyabharti College of Pharmacy, Amravati
     

   Subscribe/Renew Journal


Simple, fast and reliable derivative spectrophotometric methods were developed for determination of Buproprionhcl in bulk and pharmaceutical dosage forms. The solutions of standard and the sample were prepared in water. The quantitative determination of the drug was carried out using the zero order derivative values measured at 251 nm, the first order derivative values measured at 240 nm and the second order derivative values measured at 224 nm (n=6). Calibration graphs constructed at their wavelengths of determination were linear in the concentration range of Buproprionhcl using 10-50 μg/ml (r<SUP>2</SUP> = 0.9955, r<SUP>2</SUP> = 0.9955 and r<SUP>2</SUP> = 0.996) for zero order, first order and second order derivative spectrophotometric method. All the proposed methods have been extensively validated as per ICH guidelines. There was no significant difference between the performance of the proposed methods regarding the mean values and standard deviations. Developed spectrophotometric methods in this study are simple, accurate, precise, sensitive to assay of Buproprionhcl in tablets.

Keywords

Buproprionhcl, Derivative Spectrophotometric, Zero Order Derivative Spectrum, First Order Derivative Spectrum Andsecond Order Derivative Spectrum
Subscription Login to verify subscription
User
Notifications
Font Size


  • Loboz KK, Gross AS, Ray J, McLachlan AJ. “HPLC assay for bupropion and its major metabolites in human plasma” J. Chromatogr. B, 823(2), 115-121, 2005.
  • Richmond R, Zwar N. “Review of bupropion for smoking cessation” Drug and Alcohol Review, 22, 203-220, 2003.
  • Zhang D, Yuan B, Qiao M Li F. “HPLC determination and pharmacokinetics of sustained-release bupropion tablets in dogs” J. Pharm. Biomed. Anal., 33, 287-293, 2003.
  • Cooper TB, Suckow RF, Glassman A, “Determination of bupropion and its major basic metabolites in plasma by liquid chromatography with dual-wavelength ultraviolet detection” J. Pharm. Sci., 73(8), 1104-1107, 1984.
  • SuckowRF, Zhang MF, Cooper TB. “Enantiomeric determination of the phenylmorpholinol metabolite of bupropion in human plasma using coupled achiral-chiral liquid chromatography” Biomed. Chromatogr., 11, 174-179, 1997.
  • Yeniceli D, Dogrukol-Ak D. “An LC Method for the Determination of Bupropion and Its Main Metabolite, Hydroxybupropion in Human Plasma” Chromatographia, 70(11- 12), 1703-1708, 2009.
  • Borges V, Yang E, Dunn J, Henion J. “High-throughput liquid chromatography-tandem mass spectrometry determination of bupropion and its metabolites in human, mouse and rat plasma using a monolithic column” J. Chromatogr. B, 804, 277-287, 2004.
  • Yeniceli D, Dogrukol-Ak D. “The Retention Behaviour of Bupropion Hydrochloride in Reversed Phase Ion Pair LC and Validated Analysis of the Drug in Pharmaceuticals” Chromatographia, 71(1-2), 79-84, 2010.
  • Yeniceli D, Dogrukol-Ak D. “A Validated Thin-Layer Chromatographic Method for Analysis of Bupropion Hydrochloride in a Pharmaceutical Dosage Form” J. Planar Chromatogr., 23(3), 212-218, 2010.
  • Munro JS, Walker TA. “Bupropion hydrochloride: the development of a chiral separation using an ovomucoid column” J. Chromatogr. A, 913, 275-282, 2001.
  • Laizure SC, DeVane CL. “Stability of bupropion and its major metabolites in human plasma” Ther. Drug Monit., 7(4), 447-450, 1985.
  • Suckow RF, Smith TM, Perumal AS, Cooper TB. “Pharmacokinetics of bupropion and metabolites in plasma and brain of rats, mice and guinea pigs” Drug Metab. Dispos., 14(6), 692-697, 1986.
  • The United States Pharmacopeia XXIX, pp. 320-324, Marck Printing Co., Easton, 2006.
  • Ünal K, Palabiyik M, Karacan E, Onur F. “Spectrophotometric Determination of Amoxicillin in Pharmaceutical Formulations” Turk J. Pharm. Sci., 5(1), 1-16, 2008.
  • Tatar Ulu S. “Determination of Carbamazepine in Pharmaceutical Preparations using High Performance Liquid Chromatography and Derivative Spectrophotometry” Turk J. Pharm. Sci., 3(3), 123-139, 2006.
  • ICH Topic Q2A, Validation of Analytical Procedures: Methodology, CPMP /ICH/281/95.

Abstract Views: 361

PDF Views: 2




  • Zero Order, first Order and Second Order Derivative Spectrophotometric Methods for Determination of Buproprionhcl in Pharmaceutical formulation

Abstract Views: 361  |  PDF Views: 2

Authors

Pawan Iche
Department of Pharmaceutical Quality Assurance, Vidyabharti College of Pharmacy, Amravati

Abstract


Simple, fast and reliable derivative spectrophotometric methods were developed for determination of Buproprionhcl in bulk and pharmaceutical dosage forms. The solutions of standard and the sample were prepared in water. The quantitative determination of the drug was carried out using the zero order derivative values measured at 251 nm, the first order derivative values measured at 240 nm and the second order derivative values measured at 224 nm (n=6). Calibration graphs constructed at their wavelengths of determination were linear in the concentration range of Buproprionhcl using 10-50 μg/ml (r<SUP>2</SUP> = 0.9955, r<SUP>2</SUP> = 0.9955 and r<SUP>2</SUP> = 0.996) for zero order, first order and second order derivative spectrophotometric method. All the proposed methods have been extensively validated as per ICH guidelines. There was no significant difference between the performance of the proposed methods regarding the mean values and standard deviations. Developed spectrophotometric methods in this study are simple, accurate, precise, sensitive to assay of Buproprionhcl in tablets.

Keywords


Buproprionhcl, Derivative Spectrophotometric, Zero Order Derivative Spectrum, First Order Derivative Spectrum Andsecond Order Derivative Spectrum

References